Efficacy and safety of monotherapy and combination therapy of immune checkpoint inhibitors as first-line treatment for unresectable hepatocellular carcinoma: a systematic review, meta-analysis and network meta-analysis.

Lei, Qing; Yan, Xin; Zou, Huimin; Jiang, Yixuan; Lai, Yunfeng; Ung, Carolina Oi Lam; Hu, Hao

Lei, Qing; Yan, Xin; Zou, Huimin; Jiang, Yixuan; Lai, Yunfeng; Ung, Carolina Oi Lam; Hu, Hao.

Afiliação

Lei Q; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
Yan X; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
Zou H; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
Jiang Y; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
Lai Y; School of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou, China.
Ung COL; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
Hu H; Department of Public Health and Medicinal Administration, Faculty of Health Sciences, University of Macau, Macao SAR, China.

Discov Oncol ; 13(1): 95, 2022 Sep 28.

Article em En | MEDLINE | ID: mdl-36171533

Palavras-chave

First-line; Immune checkpoint inhibitors; Meta-analysis; Network meta-analysis; Unresectable hepatocellular carcinoma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Discov Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google